Hiromichi Ito Selected Research

Hiromichi Ito Research Topics

Disease

51	Neoplasms (Cancer) 08/2022 - 09/2003
31	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 08/2003
20	Neoplasm Metastasis (Metastasis) 06/2022 - 02/2004
20	Adenocarcinoma 01/2022 - 09/2003
4	Sinistral Portal Hypertension 10/2021 - 01/2019
3	Brain Diseases (Brain Disorder) 11/2019 - 07/2004
3	Seizures (Absence Seizure) 11/2019 - 10/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 02/2012
3	Autism Spectrum Disorder 01/2017 - 02/2013
3	Pancreatitis 12/2008 - 09/2005
2	Diarrhea 01/2022 - 01/2019
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 08/2006
2	Colic (Abdominal Cramps) 01/2019 - 01/2017
2	Pulmonary Emphysema 03/2013 - 03/2013
2	Pathologic Constriction (Stenosis) 05/2012 - 01/2011
2	Carcinoma (Carcinomatosis) 03/2011 - 10/2009
2	Chronic Pancreatitis 01/2011 - 10/2010
2	Epilepsy (Aura) 10/2005 - 10/2004
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2022
1	Hemangiosarcoma (Angiosarcoma) 04/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2022
1	Portal Hypertension 10/2021
1	Hemangioma (Angioma) 06/2021
1	Liposarcoma 06/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Hemorrhage 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2020
1	Infantile Spasms (West Syndrome) 11/2019
1	Patent Ductus Arteriosus 11/2019
1	Disease Progression 06/2019
1	Rupture 01/2019
1	Varicose Veins (Varicose Vein) 01/2019
1	Fistula 12/2018
1	Pancreatic Fistula (Pancreatic Fistulas) 10/2018
1	Due To Mecp2 Mutations Neonatal Severe Encephalopathy 01/2018

Drug/Important Bio-Agent (IBA)

14	Gemcitabine FDA Link 08/2022 - 11/2003
7	Small Interfering RNA (siRNA)IBA 08/2016 - 02/2004
5	Protons (Proton)IBA 01/2017 - 07/2008
5	Messenger RNA (mRNA)IBA 01/2016 - 10/2009
5	Cell Adhesion MoleculesIBA 10/2004 - 01/2004
5	Carcinoembryonic AntigenIBA 10/2004 - 01/2004
4	130-nm albumin-bound paclitaxelIBA 08/2022 - 02/2021
4	Immunoglobulins (Immunoglobulin)IBA 07/2004 - 08/2003
3	folfirinoxIBA 08/2022 - 04/2021
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2015 - 05/2012
3	Phosphotransferases (Kinase)IBA 08/2015 - 12/2003
3	SteroidsIBA 05/2013 - 10/2005
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2012
2	AntidiarrhealsIBA 01/2022 - 01/2019
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2004
2	Histones (Histone)IBA 12/2021 - 08/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2013
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2020
2	Zonisamide (Zonegran)FDA LinkGeneric 11/2019 - 07/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 11/2019 - 08/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2016 - 08/2015
2	RNA (Ribonucleic Acid)IBA 01/2013 - 02/2012
2	N-acetylaspartate (N-acetyl aspartate)IBA 04/2011 - 07/2008
2	GhrelinIBA 03/2008 - 09/2003
2	AutoantibodiesIBA 10/2005 - 08/2003
2	ProstaglandinsIBA 10/2004 - 05/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2004 - 05/2004
2	Prostaglandins EIBA 10/2004 - 05/2004
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 08/2004 - 02/2004
2	Peptides (Polypeptides)IBA 07/2004 - 09/2003
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2004 - 05/2004
2	Fibronectins (Fibronectin)IBA 05/2004 - 04/2004
2	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2004 - 11/2003
2	src-Family KinasesIBA 04/2004 - 08/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	AlbuminsIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 02/2021
1	hydroxide ionIBA 01/2021
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021
1	CarbohydratesIBA 02/2020
1	AntigensIBA 02/2020
1	Lamotrigine (Lamictal)FDA LinkGeneric 11/2019
1	Phenobarbital (Luminal)FDA Link 11/2019
1	WW Domain-Containing OxidoreductaseIBA 11/2019
1	Factor XIII (Coagulation Factor XIII)IBA 12/2018

Therapy/Procedure

16	Therapeutics 11/2021 - 11/2003
14	Drug Therapy (Chemotherapy) 08/2022 - 12/2003
12	Hepatectomy 06/2022 - 03/2010
10	Pancreaticoduodenectomy 02/2022 - 10/2010
6	Neoadjuvant Therapy 01/2022 - 12/2015
4	Cholecystectomy 08/2011 - 04/2008
3	Pancreatectomy 12/2021 - 01/2017
3	Ligation 10/2019 - 08/2004
2	Adjuvant Chemotherapy 05/2022 - 01/2019
2	Stents 11/2021 - 05/2012
2	Synchrotrons 09/2014 - 03/2013
2	Length of Stay 12/2009 - 09/2005
1	Laparotomy 06/2022
1	Transjugular Intrahepatic Portasystemic Shunt 10/2021
1	Laparoscopic Cholecystectomy 06/2021
1	Tracheotomy 11/2019
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 01/2019